By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone From AVANIR Pharmaceuticals (AVNR) For Phase III Initiation Of AVP-786 For Agitation In Patients With Alzheimer’s Disease 11/16/2015 10:17:47 AM
Concert Pharmaceuticals, Inc. (CNCE) Initiates Phase 1 Multiple Ascending Dose Trial With CTP-656 For Cystic Fibrosis 11/12/2015 11:04:14 AM
Concert Pharmaceuticals, Inc. (CNCE) To Present At Upcoming Investor And Industry Conferences 11/9/2015 11:52:31 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports Third Quarter 2015 Financial Results And Provides Company Update 11/5/2015 11:56:44 AM
Concert Pharmaceuticals, Inc. (CNCE) To Report Third Quarter 2015 Financial Results On November 5, 2015 10/29/2015 11:23:06 AM
Concert Pharmaceuticals, Inc. (CNCE) Highlights CTP-656 Phase 1 Results At North American Cystic Fibrosis Conference 10/9/2015 10:47:53 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces $8 Million Milestone From Celgene (CELG) 10/8/2015 10:23:53 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Results Of A Phase I Trial That Demonstrates CTP-656 Achieved A Superior Pharmacokinetic Profile To Kalydeco 9/22/2015 10:25:28 AM
Concert Pharmaceuticals, Inc. (CNCE) To Present At Three Upcoming Investor Conferences 9/2/2015 10:28:42 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports Second Quarter 2015 Financial Results And Provides Company Update 8/5/2015 11:45:33 AM
12345678910...
//-->